News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major market-moving headlines were released in the past hour.
  • No scheduled economic data or central-bank announcements occurred during the past hour.
  • No significant corporate earnings, M&A filings, or IPOs were reported in the past hour.
  • No new geopolitical incidents or government policy shifts were reported in the past hour.
  • No material regulatory actions or legal rulings affecting markets were announced in the past hour.
  • News flow was light, leaving markets without fresh catalysts in the past hour.

Latest Articles

Unity Is Back in the Spotlight - AI + VR Momentum Makes It a Tactical Long

Unity Is Back in the Spotlight - AI + VR Momentum Makes It a Tactical Long

Unity has quietly re-emerged as one of the better-positioned software plays in gaming-powered AI and virtual reality. With improving revenue growth, meaningful free cash flow and a string of product and partnership catalysts, the stock looks actionable from current levels. This trade idea lays out an entry, stop and multi-stage target with risk fra…

Digital Realty Global Data Insights Survey Reveals Enterprise Shift from AI Strategy to Execution as Infrastructure Emerges as Top Barrier

Digital Realty Global Data Insights Survey Reveals Enterprise Shift from AI Strategy to Execution as Infrastructure Emerges as Top Barrier

Digital Realty released its 2026 Global Data Insights Survey revealing that enterprises are rapidly shifting focus from AI strategy to execution, with infrastructure constraints now the primary challenge. The survey of 2,131 IT decision-makers shows a significant increase in AI spending and emphasizes the importance of distributed data strategies, …

Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend

Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend

Indivior Pharmaceuticals has declared a special cash dividend of $8.13 per share, payable to shareholders and certain equity award holders of record as of October 30, 2026. This dividend payment is contingent upon the successful completion of Indivior's merger with Supernus Pharmaceuticals, expected on or about November 2, 2026. If the merger is no…

Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

Aquestive Therapeutics has resubmitted its New Drug Application (NDA) to the FDA for Anaphylm™ (dibutepinephrine) sublingual film, aimed at treating Type I allergic reactions including anaphylaxis. The resubmission is supported by positive human factors and pharmacokinetic study results addressing the FDA's previous concerns. Anaphylm offers a smal…

Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026

Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026

Axsome Therapeutics presented ten posters at Psych Congress 2026 covering new clinical data across their psychiatry and neurology portfolio. Key topics include studies on major depressive disorder, Alzheimer's disease agitation, narcolepsy, and excessive daytime sleepiness associated with OSA. Data presentations underscore the company's progress an…

CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand

CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand

Following a CDC report highlighting a significant year-over-year increase in rabies exposures and rabies immunoglobulin use in the U.S., Kamada Ltd. confirms it has sufficient inventory and manufacturing capacity of KedRAB, one of only two FDA-approved anti-rabies immunoglobulin products. This positions Kamada to meet increasing demand driven by pu…

USA Rare Earth, Pasqal and Riven Systems Partner to Advance Next-Generation Technologies for Critical Mineral Production

USA Rare Earth, Pasqal and Riven Systems Partner to Advance Next-Generation Technologies for Critical Mineral Production

USA Rare Earth announced a strategic partnership with Pasqal, a quantum computing company, and Riven Systems, a specialist in AI for industrial chemistry, to develop next-generation separation technologies for the rare earth industry. By combining quantum machine learning with automated chemical experimentation, the collaboration seeks to identify …

NYSE:MMA - MMA.INC Engages Generation IACP to Strengthen Market Surveillance and Protect Shareholders

NYSE:MMA - MMA.INC Engages Generation IACP to Strengthen Market Surveillance and Protect Shareholders

Mixed Martial Arts Group Limited (NYSE American: MMA), operating as MMA.INC, announced an agreement with Generation IACP Inc. to utilize The Bracket™ platform for enhanced monitoring and analysis of its stock trading activities. This effort aims to detect unusual trading patterns, support market transparency, and safeguard shareholder interests. Th…

Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center

Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center

Tiziana Life Sciences, a US-listed biotech company, announced a Memorandum of Understanding with King Abdullah International Medical Research Center (KAIMRC) and the Foundation for Neurologic Diseases to collaborate on a clinical trial combining Tiziana's intranasal foralumab and anti-CD20 therapy in relapsing-remitting multiple sclerosis (RRMS) pa…

IREN's Next AI Breakout Hinges On One Operational Milestone

IREN's Next AI Breakout Hinges On One Operational Milestone

IREN has the contracts, the renewable footprint and the certification to be an AI infrastructure winner. The stock's next leg up depends on timely capacity ramp and revenue conversion from large cloud contracts. This trade proposes a tactical long at current levels with a tight stop and a target near prior highs, while acknowledging stretched valua…

Atour Lifestyle: Dormant Name, Active Upside - A Mid-Term Long Setup

Atour Lifestyle: Dormant Name, Active Upside - A Mid-Term Long Setup

Atour Lifestyle (ATAT) has been steadily expanding its hotel network and returning cash to shareholders while trading below its 52-week high. Strong revenue growth, a recurring dividend program, and a $400M buyback make the stock a compelling mid-term long. This trade idea lays out an entry, stop, and target with clear catalysts and risk controls.

Linkage Global Inc Announces 23 for 1 Share Consolidation

Linkage Global Inc Announces 23 for 1 Share Consolidation

Linkage Global Inc, a Tokyo-based AI-driven wellness technology company listed on Nasdaq, has received shareholder approval to consolidate its shares on a 23-for-1 basis. The move aims to regain compliance with Nasdaq's listing requirements and ensure continued listing on the Nasdaq Capital Market under ticker UZX with a new CUSIP number. The share…

Port MacKenzie Industry Day Highlights Nova Minerals’ Antimony Processing and Refining Project as Anchor for Alaska’s Critical Minerals Future

Port MacKenzie Industry Day Highlights Nova Minerals’ Antimony Processing and Refining Project as Anchor for Alaska’s Critical Minerals Future

Nova Minerals Corp highlighted its antimony processing and refining project at the Port MacKenzie Industry Day, showcasing its role as an anchor tenant in establishing Alaska as a strategic hub for critical minerals processing and exports. Supported by a $43.4 million award from the U.S. Department of War, the project aims to develop a domestic sup…